Impact of HIV‐1 viral subtype on disease progression and response to antiretroviral therapy

Philippa Easterbrook(World Health Organization), Mark Zuckerman, Annemiek de Ruiter(ViiV Healthcare (Spain)), Siobhan O’Shea(St Thomas' Hospital), Anna María Geretti(National Health Service), Melvyn Smith, Iain Tatt, I. L. Chrystie(St Thomas' Hospital), Jane Mullen(St Thomas' Hospital)

Journal of the International AIDS Society

January 1, 2010

10.1186/1758-2652-13-4

Cited by 162

Related Papers

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

|Nature Medicine|2002|1.6k

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

|JAMA|2016|1.4k

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

|The Lancet|2019|1k

HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

|The Journal of Experimental Medicine|2000|864

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

|The Lancet|1996|631